Skip to main content
$119.40 $0.71 (0.6%)

04:00 PM EST on 02/27/24

Abbott Laboratories Com Stk NPV (NYSE:ABT)

CAPS Rating: 4 out of 5

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Current Price $119.40 Mkt Cap $207.2B
Open $118.16 P/E Ratio 36.56
Prev. Close $119.40 Div. (Yield) $2.08 (1.7%)
Daily Range $117.83 - $119.50 Volume 3,203,311
52-Wk Range $89.67 - $120.15 Avg. Daily Vol. 5,366,062

Caps

How do you think NYSE:ABT will perform against the market?

Add Stock to CAPS Watchlist

All Players

2,485 Outperform
96 Underperform
 

All-Star Players

426 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ABT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cesturdy (< 20)
Submitted September 17, 2020

This company is more diversified than Dexcom and its glucose monitors outsells Dexcom's. Abbott also has a higher growth rate and a higher sales growth. It sell more than 1,000 products and is also a dividend aristocrat.

foolmetentimes (70.67)
Submitted January 16, 2009

I wish I had owned this stock last year....

Recent Community Commentary

Read the most recent pitches from players about ABT.

Recs

0
Member Avatar TMFWordman5150 (51.66) Submitted: 6/8/2022 9:36:00 AM : Outperform Start Price: $111.84 NYSE:ABT Score: -15.72

Abbott has been a leader for years. Concerns over its patent expiration of top selling drug Humira will eventually level out because of its 50 years of consecutive annual dividend increases. Once the pipeline of drugs (Skyrizi, Rinvoq, etc.) catch on more it will boost the stock. Healthcare is a must during any market conditions. Those that have dropped a little more than they should have due to the broader market decline will bounce back stronger.

Recs

0
Member Avatar DZBV216 (< 20) Submitted: 4/21/2022 1:56:24 PM : Outperform Start Price: $120.13 NYSE:ABT Score: -15.38

hnacx add

Recs

0
Member Avatar Dividends500 (85.54) Submitted: 3/12/2021 3:58:56 PM : Outperform Start Price: $110.67 NYSE:ABT Score: -20.77

Dividends500 tracks the healthiest dividends in the S&P 500.

To qualify for the portfolio, the company must meet three simple requirements:

- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year

Leaderboard

Find the members with the highest scoring picks in ABT.

Score Leader

TMFMojo

TMFMojo (64.81) Score: +445.99

The Score Leader is the player with the highest score across all their picks in ABT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFMojo 64.81 5/27/2006 Outperform 5Y $13.76 +767.59% +321.59% +445.99 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. GW1000 82.48 6/14/2006 4/11/2021 Outperform 5Y $13.76 +767.86% +341.87% +425.99 0 Comment
forestbin 94.79 11/10/2006 Outperform 5Y $14.69 +712.85% +289.29% +423.56 0 Comment
lucapacioli1492 < 20 11/10/2006 Outperform 3Y $14.74 +710.20% +289.75% +420.45 1 Comment
Brent1966 51.72 11/10/2006 Outperform 1Y $14.77 +708.59% +289.50% +419.09 0 Comment
BANKERTMP 69.39 11/10/2006 Outperform 5Y $14.77 +708.59% +289.50% +419.09 0 Comment
azmagno < 20 11/10/2006 Outperform 1Y $14.80 +706.75% +289.36% +417.38 0 Comment
hoftiezer < 20 11/10/2006 Outperform 5Y $14.82 +705.61% +289.39% +416.22 0 Comment
foolduke 84.03 11/14/2006 Outperform NS $14.89 +701.76% +286.59% +415.17 0 Comment
REMMAKER < 20 11/10/2006 Outperform 5Y $14.89 +701.76% +289.37% +412.39 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABT.